程序性细胞死亡
半胱氨酸蛋白酶
溶酶体
巨噬细胞
生物
结核分枝杆菌
蛋白酵素
背景(考古学)
坏死性下垂
胞浆
细胞生物学
微生物学
吞噬体
蛋白酶
弗朗西塞拉
体外
肺结核
吞噬作用
细胞凋亡
酶
生物化学
毒力
土拉弗朗西斯菌
基因
古生物学
病理
医学
作者
Ziwei Yang,Li Zhang,Samantha Ottavi,Jacob B. Geri,Andrew J. Perkowski,Xiuju Jiang,Daniel Pfau,Ruslana Bryk,Jeffrey Aubé,Matthew Zimmerman,Véronique Dartois,Carl Nathan
标识
DOI:10.1073/pnas.2425309122
摘要
Mycobacterium tuberculosis (Mtb) primarily infects macrophages. In vitro without antibiotics, wild-type Mtb hastens death of the macrophages, but the processes leading to rapid cell death are not well understood. Our earlier work indicated that the death of Mtb-infected mouse macrophages in vitro is markedly exacerbated by induction of interferon-β (IFN-β) [L. Zhang et al., J. Exp. Med. 18 , e20200887 (2021)]. Here, we identified a key downstream response to IFN-β in the context of Mtb infection as the massive induction of cis-aconitate decarboxylase (ACOD1), not only in its canonical subcellular localization in mitochondria but also in the cytosol, where it bound to the lysosome-stabilizing protein HSP70. ACOD1’s product, itaconate, protected Mtb-infected macrophages. However, the contrasting and predominant effect of high-level ACOD1 expression was to act in a noncatalytic manner to promote HSP70’s degradation, leading to lysosomal membrane permeabilization (LMP). Mtb-induced macrophage death was markedly diminished by inhibitors of cysteine proteases, consistent with lysosome-mediated cell death. Neither ACOD1 inhibitors nor cysteine protease inhibitors are suitable for potential host-directed therapy (HDT) of tuberculosis. Instead, this work directs attention to how ACOD1 acts nonenzymatically to promote the degradation of HSP70.
科研通智能强力驱动
Strongly Powered by AbleSci AI